Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment.
about
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host DiseaseHow I treat acute graft-versus-host disease of the gastrointestinal tract and the liver.Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.Steroids Versus Steroids Plus Additional Agent in Frontline Treatment of Acute Graft-versus-Host Disease: A Systematic Review and Meta-Analysis of Randomized Trials.Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation.Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide.B Lymphocyte Chemoattractant (CXCL13) Is an Indicator of Acute Gastrointestinal GVHD in Murine Model.Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.Associations between levels of insulin-like growth factor 1 and sinusoidal obstruction syndrome after allogeneic haematopoietic stem cell transplantation.The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review.hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation.Editorial: Danger Signals Triggering Immune Response and Inflammation.Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.Plasma vascular non-inflammatory molecule 3 is associated with gastrointestinal acute graft-versus-host disease in mice.Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation.Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft versus host disease: low incidence of lower gastrointestinal tract disease.A proposed biology- and biomarker-based algorithm for management of acute GvHD.Biomarkers for post-transplantation outcomes.Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.Peripheral tissues reprogram CD8+ T cells for pathogenicity during graft-versus-host disease.Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantation.Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation
P2860
Q33593742-41E2A68D-ECA4-4824-8182-4D967002397AQ33809599-C6AD31CD-36E2-40C6-B6DF-9B4BDA2C9789Q36039542-A377AC9A-3ED9-442F-A690-64F564930F9BQ36727862-CDDAFB5D-248A-472D-BD8F-445798E902B0Q36904560-422667D8-F73C-4237-ABCE-9DE957A766B4Q36925951-3178ECFA-1E36-4F1C-B6D7-B7E82BBA901FQ37302887-A6A51A2D-6A35-416C-ACC1-42E99BF5C8F7Q37585022-0C23AA7C-87B1-45DB-AB57-980A13BEFE7FQ37696092-F315DF8F-12D7-44DC-BC9F-6DDCF62AE94AQ38381708-09390C7C-285F-4A5B-B93A-F5122859D086Q38688669-39FFDFBA-179A-4489-8CB7-CB68F0C1EB83Q38800455-C423E1CA-4F4F-4B1A-A328-F5A9990D3693Q38823218-7541B630-1B6C-46A6-9848-419FD48EBEDDQ38829335-1ADD1C64-2E0D-432D-9D08-9C4656B0E5CEQ38835327-2FF62E5C-9E74-4F25-872A-31D8D0FAA1B9Q42345013-9F9E1A89-A034-4362-9F26-D283551E07B5Q47136178-B2B535B5-0441-4DCF-9096-A7D4CFCE98F4Q47222414-34C720C5-501F-4E67-BC49-8B2A116B9ED0Q47312420-3E7FD816-3281-4D00-A9F7-F26CDD6468EAQ49806345-86150737-5EA3-4F24-82E8-D3ABBF9D3779Q49912604-97911812-78B8-41EE-84DD-60D8AA0E09AEQ50545248-31701749-128F-4257-B269-2C8ADABEE023Q52603913-678BD779-AE39-4445-8138-E4D052B1AA48Q52667946-E30474E8-D80B-498F-AE6D-E83938B3E35EQ55260254-C056336B-801C-49E6-81DA-07755F9352E8Q55352576-E2DE7B95-DCCE-4F35-B1B8-D7C2906EBEE3Q58710237-001F493D-4EC3-41F9-9F7C-80FBE8E9090A
P2860
Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Plasma biomarkers of acute GVH ...... fore GVHD onset and treatment.
@ast
Plasma biomarkers of acute GVH ...... fore GVHD onset and treatment.
@en
type
label
Plasma biomarkers of acute GVH ...... fore GVHD onset and treatment.
@ast
Plasma biomarkers of acute GVH ...... fore GVHD onset and treatment.
@en
prefLabel
Plasma biomarkers of acute GVH ...... fore GVHD onset and treatment.
@ast
Plasma biomarkers of acute GVH ...... fore GVHD onset and treatment.
@en
P2860
P50
P1433
P1476
Plasma biomarkers of acute GVH ...... fore GVHD onset and treatment.
@en
P2093
Barry E Storer
Richard L Lawler
P2860
P304
P356
10.1182/BLOOD-2015-03-636753
P407
P577
2015-05-18T00:00:00Z